(Q35429376)

8 August 2017

title

Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis (English)

1 reference

8 August 2017

main subject

phase I clinical trial

0 references

informed consent

0 references

informed consent form

0 references

author name string

Kimmelman J

series ordinal

1

1 reference

8 August 2017

Palmour N

series ordinal

2

1 reference

8 August 2017

publication date

1 April 2005

1 reference

Journal of Medical Ethics

8 August 2017

published in

1 reference

8 August 2017

volume

31

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

209-214

1 reference

Quality of informed consent in cancer clinical trials: a cross-sectional survey

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Defining and describing benefit appropriately in clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Phase I cancer trials. A collusion of misunderstanding.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Shared understandings for informed consent: the relevance of psychological research on the provision of information.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

The impact of disease severity on the informed consent process in clinical research.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

False hopes and best data: consent to research and the therapeutic misconception

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Responses and toxic deaths in phase I clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Uncertain benefit: investigators' views and communications in early phase gene transfer trials.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Attitudes towards clinical research amongst participants and nonparticipants.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

What patients say about medical research.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Genetic research as therapy: implications of "gene therapy" for informed consent

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Ethics of clinical trials. Do they help the patient?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Perceptions of cancer patients and their physicians involved in phase I trials

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Experimental Treatment Oxymoron or Aspiration?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Descriptions of benefits and risks in consent forms for phase 1 oncology trials

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Informed consent for investigational chemotherapy: patients' and physicians' perceptions

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

Protecting the scientific integrity of a clinical trial: some ethical dilemmas

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

On the nature and ethics of phase I clinical trials of cancer chemotherapies

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1734123

The impact of HIV infection on society's perception of clinical trials

15 November 2018

1 reference

12 December 2020

Nonfinancial conflicts of interest in research

1 reference

12 December 2020

Therapeutic response in phase I trials of antineoplastic agents

1 reference

12 December 2020

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

12 December 2020

Identifiers

DOI

10.1136/JME.2003.006247

1 reference

8 August 2017

1 reference

8 August 2017

1 reference